Cancer associated serum antigen (CASA) levels in patients with breast carcinoma and in 3 control groups without breast cancer.

Abstract	We have examined the predictive value of measurements of CASA (Cancer Associated Serum Antigen) levels in patients with breast carcinoma. The measurement uses monoclonal antibodies that bind to an epitope on the polymorphic epithelial mucin. CASA levels were of less value compared with the levels of other tumor markers (CA 15-3, CA 549 and CEA) in the management of patients with early breast cancer.
Authors	M Meisel, J Weise, G Schwesinger, W Straube
Journal	Archives of gynecology and obstetrics (Arch Gynecol Obstet) Vol. 261 Issue 3 Pg. 159-62 ( 1998) ISSN: 0932-0067 [Print] Germany
PMID	9651660 (Publication Type: Journal Article)
Chemical References	Biomarkers, Tumor Mucin-1
Topics	Adult Aged Aged, 80 and over Biomarkers, Tumor (blood) Breast (pathology) Breast Neoplasms (blood, diagnosis, pathology) Female Fibrocystic Breast Disease (blood, diagnosis, pathology) Humans Middle Aged Mucin-1 (blood) Neoplasm Staging Prognosis Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!